Alzheimerโs Drug Discovery Foundationโs Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimerโs Disease todayheadline
The Alzheimerโs Drug Discovery Foundation (ADDF)โs Diagnostics Accelerator (DxA) today announced a $10M investment in Alamar Biosciences, Inc. This landmark investment,...
Read moreDetails